Sort
50,496 grants matching “lung cancer”
Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer
$621,239Ming You · Medical College Of Wisconsin · R01 · FY2019 · CA
Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency
$621,211Jerome Ritz · Dana-Farber Cancer Inst · UG1 · FY2017 · EY
The Effectiveness, Safety, and Costs of Guideline-Concordant Lung Nodule Care
$621,132Farhood Farjah · University Of Washington · R01 · FY2018 · CA
Developing Mathmatical Framework to Uncover the Sequence of Genetic Events During
$621,050Franziska Michor · Dana-Farber Cancer Inst · U54 · FY2013 · CA
Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
$620,991Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · U01 · FY2021 · CA
GENETIC EPIDEMIOLOGY OF LUNG CANCER
$620,988Wayne State University · R01 · FY2000 · CA
Resorbable Inferior Vena Cava Filter
$620,973Mitchell Eggers · Adient Medical, Inc. · R44 · FY2016 · HL
Chemoprevention of lung cancer with mitochondria-targeted honokiol
$620,971Ming You · Medical College Of Wisconsin · R01 · FY2017 · CA
New Faculty Recruitment in Stem Cell and Regenerative Cardiovascular Biology
$620,961Allen W Cowley · Medical College Of Wisconsin · P30 · FY2009 · HL
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
$620,949Suresh S Ramalingam · Emory University · U10 · FY2015 · CA
PennPET Explorer Scanner With Scalable Axial Length for Total Body PET Imaging
$620,935Joel S Karp · University Of Pennsylvania · R01 · FY2020 · CA
Basic applications for total-body PET in oncology
$620,929Lorenzo Nardo · University Of California At Davis · R01 · FY2020 · CA
Methods and Tools for Integrating Pathomics Data into Cancer Registries
$620,871Joel H Saltz · State University New York Stony Brook · UH3 · FY2021 · CA
miRNA Regulation of Vascular Permeability and Inflammation in the Lung Injury
$620,850Eva Nozik Grayck · University Of Colorado Denver · R01 · FY2014 · HL
HLA B44 motif neoepitopes in NSCLC: Evaluating their effects on the TME and adding them to established markers in a model to predict durable benefit from PD- 1 inhibition with and without chemotherapy
$620,831Edward B Garon · University Of California Los Angeles · R01 · FY2023 · CA
CANCAN-RUTGERS
$620,805Eileen White · Rutgers Biomedical And Health Sciences · OT2 · FY2024 · CA
Multiplexed Nanosensing for DNA and Proteins
$620,767Richard James Cote · University Of Miami School Of Medicine · R01 · FY2009 · EB
Multi-scale model of microbial phenotype modulation by mucins
$620,713Jason Papin · University Of Virginia · R01 · FY2023 · AI
Multi-scale model of microbial phenotype modulation by mucins
$620,713Jason Papin · University Of Virginia · R01 · FY2024 · AI
Multi-scale model of microbial phenotype modulation by mucins
$620,713Jason Papin · University Of Virginia · R01 · FY2022 · AI
Phase 1 Evaluation of Enhanced Natural Killer Cells as a Treatment Strategy in Non-Small cell Lung Cancer Patients Refractory to PD-1/PD-L1 Immune Checkpoint Inhibitors
$620,673Miguel Angel Villalona · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
The Positively Quit Trial: Addressing disproportionate smoking rates among people living with HIV
$620,648Stephanie Lynn Marhefka · University Of South Florida · R01 · FY2019 · CA
Developing SWIR fluorophores for enhanced visualization of buried nerves in head and neck cancer surgery
$620,592Lei Garrett Wang · Oregon Health & Science University · R56 · FY2025 · DE
A blood test to identify prostate cancer patients at risk for visceral metastasis
$620,500Edwin Melencio Posadas · Cedars-Sinai Medical Center · R01 · FY2017 · CA
Lung Tissue Engineering
$620,474Laura E Niklason · Yale University · R01 · FY2012 · HL